Progenics(美國)

Progenics Pharmaceuticals

ProgenicsPharmaceuticalswww.progenics.comProgenics制藥ProgenicsPharmaceuticals,Inc.,ofTarrytown,N.Y.,isabiopharmaceuticalcompanyfocusedoninnovativetherapeuticsforpatientssufferingfromcancerandrelatedcon ditions.Progenics'pipelinecandidatesincludePSMAADC,ahumanmonoclonalantibody-drugconjugateinphase2testingfortreatmentofprostatecancer,andpreclinicalstagenovelmultiplexphosphoinositide3-kinase(PI3K)inhibitorsforthetreatmentofcancer.Progenicshasexclusivelylicenseddevelopmentandcommercializationrightsforitsfirstcommercialproduct,RELISTOR®,toSalixPharmaceuticals,Ltd.formarketsworldwideotherthanJapan,whereOnoPharmaceuticalCo.,Ltd.holdsanexclusivelicenseforthesubcutaneousformulation.RELISTOR(methylnaltrexonebromide)SubcutaneousInjectionisafirst-in-classtreatmentforopioid-inducedconstipationapprovedinmorethan50countriesforpatientswithadv